Avid bioservices, inc. (CDMO)
Income statement / Quarterly
Jan'20Oct'19Jul'19Apr'19Jan'19Oct'18Jul'18Apr'18Jan'18Oct'17Jul'17Apr'17Jan'17Oct'16Jul'16Apr'16Jan'16Oct'15Jul'15Apr'15Jan'15Oct'14Jul'14Apr'14Jan'14Oct'13Jul'13Apr'13Jan'13Oct'12Jul'12Apr'12Jan'12Oct'11Jul'11Apr'11Jan'11Oct'10Jul'10
Contract manufacturing revenue

-

-

-

-

-

-

-

-

-

-

-

-

10,747

23,370

5,609

-

6,672

9,523

9,379

9,308

5,677

6,263

5,496

6,474

3,885

7,354

4,581

4,176

6,961

6,061

4,135

1,987

3,203

4,154

5,439

1,970

1,922

3,627

983

Government contract revenue

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

681

882

966

2,111

License revenue

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

37

0

292

0

0

37

0

0

0

0

107

78

78

78

116

78

78

78

216

78

79

78

115

Revenues

13,585

18,313

15,254

17,055

13,781

10,178

12,589

6,943

6,819

12,782

27,077

-

-

-

-

18,454

6,709

9,523

9,671

9,308

5,677

6,300

5,496

6,474

3,885

7,354

4,688

4,254

7,039

6,139

4,251

2,065

3,281

4,232

5,655

2,729

2,883

4,671

3,209

Cost of revenues

12,800

14,953

14,168

13,407

11,731

9,844

11,397

8,904

10,951

16,242

20,448

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Cost of contract manufacturing

-

-

-

-

-

-

-

-

-

-

-

-

7,974

15,441

3,062

-

3,896

4,741

4,608

4,758

3,113

4,139

3,583

3,829

2,416

4,195

2,670

3,217

3,651

3,703

2,024

934

2,484

3,718

3,017

1,411

1,726

3,003

1,156

Gross profit

785

3,360

1,086

3,648

2,050

334

1,192

-1,961

-4,132

-3,460

6,629

-

2,773

7,929

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Operating expenses:
Selling, general and administrative

2,996

3,534

4,459

3,573

3,242

2,816

3,215

4,183

4,824

3,596

3,853

3,670

4,365

4,984

5,060

4,065

4,524

4,416

4,899

5,188

4,325

4,295

4,883

4,361

4,563

4,016

4,334

3,665

3,112

3,440

2,917

3,091

2,710

2,732

2,929

3,274

2,947

2,702

2,498

Loss on lease termination

0

-355

-

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Restructuring charges

-

-

-

-

-

-

-

-

0

1,258

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Total operating expenses

2,996

3,889

-

-

3,242

2,816

-

-

4,824

4,854

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Research and development

-

-

-

-

-

-

-

-

-

-

-

-

-

7,022

8,569

-

15,156

14,190

13,918

11,531

11,261

10,003

10,201

8,813

6,649

6,957

5,304

5,835

5,437

6,053

6,981

8,930

9,180

9,818

7,760

7,998

7,053

7,344

7,067

Restructuring charges

-

-

-

-

-

-

-

-

-

-

-

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Total operating expenses

-

-

-

-

-

-

-

-

-

-

-

-14,983

4,365

12,006

16,691

-52,444

23,576

23,347

23,425

21,477

18,699

18,437

18,667

17,003

13,628

15,168

12,308

12,717

12,200

13,196

11,922

12,955

14,374

16,268

13,706

12,683

11,726

13,049

10,721

Operating loss

-2,211

-529

-3,373

75

-1,192

-2,482

-2,023

-6,144

-8,956

-8,314

2,776

18,043

-1,592

-4,077

-11,082

47,932

-16,867

-13,824

-13,754

-12,169

-13,022

-12,137

-13,171

-10,529

-9,743

-7,814

-7,620

-8,463

-5,161

-7,057

-7,671

-10,890

-11,093

-12,036

-8,051

-9,954

-8,843

-8,378

-7,512

Interest and other income, net

107

99

209

92

9

119

62

7

28

13

27

30

25

21

25

-567

34

626

31

34

29

37

42

281

23

24

21

15

255

44

8

10

9

9

13

18

20

996

18

Interest and other expense

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

14

-

-

-

-

-

-

-

4

0

1

1

8

44

1

2

6

28

54

78

106

131

201

Total other income, net

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

20

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Interest and other expense

-

-

-

-

-

-

-

-

-

-

3

-

2

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Loss from continuing operations before income taxes

-2,104

-430

-

-

-1,183

-2,363

-

-6,134

-8,928

-8,301

2,800

-

-1,569

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Income tax benefit

0

0

-

-

-44

-173

-

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Loss from continuing operations, net of tax

-2,104

-430

-

-

-1,139

-2,190

-

-

-8,928

-8,301

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Income from discontinued operations, net of tax

0

0

-

-

0

739

-

9,154

-2,076

-4,323

-4,005

-

-6,205

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Interest and other expense

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

1

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Total other income (expense), net

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

28

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Loss on early extinguishment of debt

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

0

-1,696

-

-

0

0

-

-

-

-

-

Net Loss

-2,104

-430

-3,164

336

-1,139

-1,451

-1,961

3,020

-11,004

-12,624

-1,205

-5,272

-7,774

-4,056

-11,057

-11,884

-16,847

-13,198

-13,723

-12,135

-12,994

-12,100

-13,129

-10,248

-9,724

-7,790

-7,600

-8,449

-4,914

-8,753

-7,664

-10,882

-11,090

-12,055

-8,092

-10,014

-8,929

-7,513

-7,695

Comprehensive loss

-2,104

-430

-3,164

336

-1,139

-1,451

-1,961

3,020

-11,004

-12,624

-1,205

-5,272

-7,774

-4,056

-11,057

-11,884

-16,847

-13,198

-13,723

-12,135

-12,994

-12,100

-13,129

-10,248

-9,724

-7,790

-7,600

-8,449

-4,914

-8,753

-7,664

-10,882

-11,090

-12,055

-8,092

-

-

-

-

Series E preferred stock accumulated dividends

-

-

-

-

-

-

-

-

1,442

1,442

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Series E preferred stock accumulated dividends

1,442

1,442

1,442

360

1,442

1,442

1,442

-

-

-

1,442

376

1,442

1,442

1,380

346

1,380

1,380

1,378

604

1,033

1,031

1,028

-

0

-

0

-

-

-

-

-

-

-

-

-

-

-

-

Net loss attributable to common stockholders

-3,546

-1,872

-4,606

-24

-2,581

-2,893

-3,403

2,660

-12,446

-14,066

-2,647

-5,648

-9,216

-5,498

-12,437

-12,230

-18,227

-14,578

-15,101

-12,739

-14,027

-13,131

-14,157

-

-9,724

-

-7,600

-

-

-

-

-

-

-

-

-

-

-

-

Basic and diluted net (loss) income per common share attributable to common stockholders: Continuing Operations

-0.06

-0.03

-

-

-0.05

-0.06

-

-0.03

-0.23

-0.21

-0.06

-

-0.08

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net (loss) income per common share attributable to common stockholders - Diluted, Continuing operations

-

-

-

-

-

-

-

-

-

-

0.03

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net (loss) income per common share attributable to common stockholders - Diluted, Disontinued operations

-

-

-

-

-

-

-

-

-

-

-0.09

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Basic and diluted net (loss) income per common share attributable to common stockholders: Discontinued Operations

0.00

0.00

-

-

0.00

0.01

-

0.18

-0.05

-0.10

-0.06

-

-0.17

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net loss per common share attributable to common stockholders

-0.06

-0.03

-0.08

0.00

-0.05

-0.05

-0.06

-

-0.28

-0.31

-

-0.11

-0.25

-0.16

-0.36

-1.72

-0.08

-0.07

-0.08

-1.84

-0.08

-0.07

-0.08

-0.06

-0.06

-0.05

-0.05

-0.06

-0.04

-0.08

-0.07

-0.10

-0.13

-0.16

-0.11

-0.15

-0.14

-0.13

-0.14

Weighted average common shares outstanding - Basic

-

-

-

-

-

-

-

-

-

-

44,773

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

64,374

56,761

-

Weighted average common shares outstanding - Diluted

-

-

-

-

-

-

-

-

-

-

44,877

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net (loss) income per common share attributable to common stockholders - Basic, Continuing operations

-

-

-

-

-

-

-

-

-

-

0.03

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net (loss) income per common share attributable to common stockholders - Basic, Disontinued operations

-

-

-

-

-

-

-

-

-

-

-0.09

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Weighted average basic and diluted shares outstanding

56,404

56,253

56,167

56,076

56,069

56,009

55,770

-

45,225

45,097

-

41,977

37,258

34,973

34,227

-505,068

227,389

203,942

197,317

-437,281

182,519

179,962

179,118

176,752

163,223

156,948

149,393

137,301

131,489

109,405

103,283

98,961

87,149

77,523

70,656

-

-

-

-